Darren Wan-Teck Lim
机构: National Cancer Center Singapore; Duke-NUS Medical School National University of Singapore
每年引用次数
引用次数
引用: 13,844
H-指数: 55
I10-指数 : 139
出版物: 405
Association of clinical factors with survival outcomes in laryngeal squamous cell carcinoma (LSCC).
Pei Yuan Fong , Sze Huey Tan , Darren Wan Teck Lim , Eng Huat Tan
PLOS ONE 14 ( 11)
4
2019
Life-Threatening Pneumonitis Related to Docetaxel Chemotherapy
Mei-Kim Ang , Darren Wan Teck Lim , Eng Huat Tan , Quan Sing Ng
Proceedings of Singapore Healthcare 24 ( 1) 54 -58
1
2015
The CANOPY program: Canakinumab in patients (pts) with non-small cell lung cancer (NSCLC).
Luis G Paz-Ares , Edward B Garon , Andrea Ardizzoni , Fabrice Barlesi
Journal of Clinical Oncology 37 ( 15)
7
2019
Efficacy of Anti-PD1 Blockade in Treating Recurrent or Metastatic Nasopharyngeal Cancer: A Systematic Review and Meta-analysis
Brian Sheng Yep Yeo , Harris Jun Jie Muhammad Danial Song , Yoke Lim Soong , Melvin Lee Kiang Chua
Oral Oncology 136 106242
2023
Molecular testing in non-small cell lung cancer: A consensus recommendation
Gillianne Geet Yi Lai , Xin Min Cheng , Yvonne Li’en Ang , Kevin Lee Min Chua
Call for Papers 52 ( 7) 364 -73
2023
Multidisciplinary lung cancer clinic: An emerging model of care
Stephanie Pei Li Saw , Kevin Lee Min Chua , Boon Hean Ong , Darren Wan Teck Lim
Annals of the Academy of Medicine, Singapore 51 ( 12) 793 -795
2022
Correspondence re: Cecchin et al., Carboxylesterase isoform 2 mRNA expression in peripheral blood mononuclear cells is a predictive marker of the irinotecan to SN38 activation step in colorectal cancer patients. Clin Cancer Res 2005;11:6901-7.
Balram Chowbay , Srinivas Rao Jada , Darren Lim Wan Teck
Clinical Cancer Research 12 ( 6) 1942 -1942
3
2006
First-in-Human, Healthy Volunteers Integrated Protocol of ETC-206, an Oral Mnk 1/2 Kinase Inhibitor Oncology Drug
Vincenzo Teneggi , Veronica Novotny‐Diermayr , Lay Hoon Lee , Maryam Yasin
Clinical and Translational Science 13 ( 1) 57 -66
8
2020
Healthy Volunteers' Integrated Protocol of ETC-206, an Oral MNK 1/2 Kinase Inhibitor Oncology Drug (vol 13, pg 57, 2020)
Vincenzo Teneggi , Veronica Novotny-Diermayr , Lay Hoon Lee , Maryam Yasin
CTS-CLINICAL AND TRANSLATIONAL SCIENCE 14 ( 1) 422 -425
2021
Measuring quality of life in Chinese cancer patients: a new version of the Functional Living Index for Cancer (Chinese).
Tay Mh , Koo Wh , Tan Eh , Tan Sb
Annals Academy of Medicine Singapore 32 ( 3) 376 -380
11
2003
Detection and prognostic relevance of circulating tumour cells (CTCs) in breast cancer (BC) using the ClearCell® FX platform
Y.-S. Yap , G. Singh , Y. Lee , K. Loh
The Breast 32 S108
2017
Inhibition of Corneal Neovascularization by Brain–specific Angiogenesis Inhibitor 1 Gene Delivery
K.–Y. Ahn , K.–C. Yoon , D.–W. Lim , M.–S. Seo
Investigative Ophthalmology & Visual Science 45 ( 13) 4815 -4815
2004
Efficacy and safety of apatinib in recurrent/metastatic nasopharyngeal carcinoma: A pilot study.
Joseph T.S. Wee , Melvin L.K. Chua , Sze Huey Tan , Yongzhong Wu
Oral Oncology 115 105222
2021
Variable problems in lymphomas: CASE 1. Burkitt's lymphoma presenting with central airway obstruction.
Su Pin Choo , Darren W.T. Lim , Constance P.L. Lo , Heng Nung Koong
Journal of Clinical Oncology 23 ( 31) 8112 -8113
3
2005
Experience from Asian centers in a named-patient-use program for afatinib in patients with advanced non-small-cell lung cancer who had progressed following prior therapies, including patients with uncommon EGFR mutations
Chun-Ming Tsai , Sang-We Kim , Keunchil Park , Yuh-Min Chen
International Journal of Clinical Oncology 26 ( 5) 841 -850
2021
Detection and prognostic relevance of circulating tumour cells (CTCs) in Asian breast cancers using a label-free microfluidic platform.
Yoon-Sim Yap , Man Chun Leong , Yong Wei Chua , Kiley Wei Jen Loh
PLOS ONE 14 ( 9)
12
2019
Abstract CT203: A phase II trial of ipilimumab in combination with nivolumab in EBV-associated advanced nasopharyngeal carcinoma (NCT03097939)
Darren Wan-Teck Lim , Quan Sing Ng , Ruey-Long Hong , Daniel S. Tan
Cancer Research 80
2020
Abstract CT171: Phase I study of BLZ945 alone and with spartalizumab (PDR001) in patients (pts) with advanced solid tumors
Chia-Chi Lin , Marta Gil-Martin , Todd M. Bauer , Aung Naing
Cancer Research 80
19
2020
Abstract CT286: CANOPY program clinical trials: Canakinumab (Cana) in patients (pts) with non-small cell lung cancer (NSCLC)
Luis Paz-Ares , Edward B Garon , Tony Mok , Andrea Ardizzoni
Cancer Research 80
1
2020
Nasopharyngeal carcinoma: distant metastasis
Wu-Meng Tan , Darren Wan-Teck Lim
Nasopharyngeal Carcinoma: Management Strategies 151 -165
2014